NL-OMON55652已完成不适用
Multi-Center Clinical Evaluation of the ATTUNE® Revision System in Revision Total Knee Arthroplasty - DSJ-2016-02: Attune revision
Cturn0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •* Subject is male or female and between the ages of 22 and 80 years at the time
- •of consent, inclusive.
- •* Subject presents with a primary knee arthroplasty (primary TKA,
- •unicompartmental) or prior revision TKA that requires a revision procedure of
- •implanted tibial and/or femoral components.
- •* The decision to perform a knee revision with the study device is regardless
- •of the research.
- •* Subject that is willing to give voluntary, written informed consent to
- •participate in this clinical investigation and authorize the transfer of
- •his/her information to the Sponsor
- •* Subject is currently not bedridden
- •* The devices are to be used according to the approved indications.Subject is
- •able to read, and comprehend the Informed Consent Document as well as complete
- •the required PROMs in either English or one of the available translations.
排除标准
- •* The Subject is a woman who is pregnant or lactating.
- •* Contralateral knee has already been enrolled in this study.
- •* Subject had a contralateral amputation.
- •* Subject is currently diagnosed with radicular pain from the spine that
- •radiates into the limb to receive RTKA.
- •* Subject has participated in a clinical investigation with an investigational
- •product (drug or device) in the last three (3) months.
- •* Subject is currently involved in any personal injury litigation,
- •medical-legal or worker's compensation claims.
- •* Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in
- •the last 5 years) or has a psychological disorder that could affect his/her
- •ability to complete patient reported questionnaires or be compliant with
- •follow-up requirements.
- •* Subject was diagnosed and is taking prescription medications to treat a
- •muscular disorder that limits mobility due to severe stiffness and pain such as
- •fibromyalgia or polymyalgia.
- •* Subject has a significant neurological or musculoskeletal disorder(s) or
- •disease that may adversely affect gait or weight bearing activities (e.g.,
- •muscular dystrophy, multiple sclerosis, Charcot disease).
- •* Subject has a medical condition with less than five (5) years life expectancy
- •as determined by the Investigator.
- •* Uncontrolled gout
研究者
相似试验
招募中
不适用
Multi-Center Clinical Evaluation of the ATTUNE® Revision System in Complex Primary Total Knee ArthroplastyNL-OMON54830Cturn20
招募中
不适用
Multi-Center Clinical Evaluation of the ATTUNE® Cementless Rotating Platform Total Knee Arthroplastyosteoarthritis (OA) or post-traumatic arthritis and Non-inflammatory Degenerative Joint Disease1002321310005944NL-OMON50255DePuy Synthes Joint Reconstruction Inc65
进行中(未招募)
不适用
ATTUNE Revision System in the Revision Total Knee Arthroplasty PopulationRevision Total Knee ArthroplastyNCT03153475DePuy Orthopaedics400
进行中(未招募)
不适用
ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty PopulationPrimary Knee ArthroplastyNCT03153449DePuy Orthopaedics400
终止
不适用
ATTUNE Cementless FB Tibial Base Clinical StudyOsteoarthritis of the KneeNCT04630262DePuy Orthopaedics80
